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RESEARCH ARTICLE Open Access
Multimodal lifestyle intervention using a
web-based tool to improve cardiometabolic
health in patients with serious mental
illness: results of a cluster randomized
controlled trial (LION)
Anne Looijmans1* , Frederike Jörg2,3, Richard Bruggeman2,4, Robert A. Schoevers4 and Eva Corpeleijn5
Abstract
Background: Unhealthy lifestyle behaviours contribute to alarming cardiometabolic risk in patients with serious
mental illness (SMI). Evidence-based practical lifestyle tools supporting patients and staff in improving patient
lifestyle are lacking.
Methods: This multi-site randomized controlled pragmatic trial determined the effectiveness of a twelve-month
multimodal lifestyle approach, including a web-based tool to improve patients’ cardiometabolic health, versus
care-as-usual. Using the web tool, nurses (trained in motivational interviewing) assisted patients in assessing
their lifestyle behaviours, creating a risk profile and constructing lifestyle goals, which were discussed during
fortnightly regular care visits. Twenty-seven community-care and sheltered-living teams were randomized into
intervention (N = 17) or control (N = 10) groups, including 244 patients (140 intervention/104 control, 49.2%
male, 46.1 ± 10.8 years) with increased waist circumference (WC), BMI or fasting glucose. The primary outcomes
concerned differences in WC after six and twelve months intervention, while BMI and metabolic syndrome Z-
score were secondary outcome measures.
Results: General multilevel linear mixed models adjusted for antipsychotic medication showed that differences
in WC change between intervention and control were − 0.15 cm (95%CI: − 2.49; 2.19) after six and − 1.03 cm
(95%CI: − 3.42; 1.35) after twelve months intervention; however, the differences were not statistically significant.
No intervention effects were found for secondary outcome measures. The intervention increased patients’
readiness to change dietary behaviour.
Conclusion: A multimodal web-based intervention facilitating nurses to address lifestyle changes in SMI
patients did not improve patient cardiometabolic health. Web-tool use was lower than expected and nurses
need more lifestyle coaching knowledge and skills. The type of intervention and delivery mode need
optimization to realize effective lifestyle care for SMI patients.
Trial registration: Dutch Trial Registry, www.trialregister.nl, NTR3765, 21 December 2012.
Keywords: Serious mental illness, Metabolic syndrome, Healthy lifestyle, Motivational interviewing, Health
behaviour change, E-health, Physical activity
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Background
Among people with a serious mental illness (SMI), such
as schizophrenia or other psychotic or bipolar disorders,
the prevalence of obesity is 45–55%, while 10–15% have
type 2 diabetes [1], which is almost four times higher
than in the general population. Lifestyle interventions
have proven to be effective in improving such cardio-
metabolic risk factors [2–4]. Most lifestyle interventions
are relatively short and intense programmes that usually
have at least three key components: exercise, diet and
behavioural therapy [3, 4]. Although these interventions
are effective in the short term, the benefits are seldom
sustained in the long term. The literature shows that
while interventions aimed at making small but sustain-
able changes in lifestyle behaviour – the ‘small steps ap-
proach’ – only lead to small weight changes in the short
term, they prevent weight regain and result in more
structural weight loss in the long term because such
small changes can be sustained [5–7].
The small-steps approach is of interest to clinical care,
insofar as it might be easier to implement in the daily
care of patients than other interventions. It may also be
suitable for any patient and not just those who are highly
motivated and stable. For patients who are already moti-
vated to change their behaviour, behavioural therapy
strategies such as goal setting, making action plans and
self-monitoring tend to work well [8]. It is known that
unless motivational aspects are addressed explicitly, car-
rying out lifestyle interventions in a vulnerable and less
motivated population will not lead to health improve-
ments [9].
One effective approach to deal with unmotivated pa-
tients or those who are not ready to make changes is
motivational interviewing (MI), developed by Miller and
Rollnick [10], and including the stages-of-change con-
struct from the Transtheoretical Model of Prochaska
and DiClemente [11]. MI is a patient-centred counsel-
ling approach that targets behaviour change by strength-
ening a person’s own motivation and commitment using
the ambivalence between their goals and behaviour. MI
is effective in targeting lifestyle changes, such as improv-
ing weight status, Body Mass Index (BMI) and choles-
terol levels of overweight and obese adults, and of
clients in a broad range of other domains [12–14]. Ac-
cording to the stages-of-change model, a patient’s level
of self-efficacy and readiness to change is reflected in
one of five stages of change [15, 16]: precontemplation,
contemplation, preparation, action and maintenance.
These stages range from ‘no intention to change’ to
‘maintenance of behaviour change’. Treatment (or inter-
vention) should adapt to a patient’s stage of change for
maximum uptake of an intervention [15], for example
creating awareness in the precontemplation stage and
increasing intrinsic motivation in the preparation phase.
MI is used to guide the patient’s transition from one
stage to the other.
New technologies offer new opportunities for interven-
tion. E-Health and m-Health technology has proven to
be feasible and acceptable in the SMI patient population
with regard to illness self-management and relapse pre-
vention, adherence to medication, psycho-education and
symptom monitoring [17]. To date, these technologies
have rarely been used to address lifestyle behaviours in
this patient population [17, 18], although results of pilot
studies are emerging [19].
The current study presents a multimodal lifestyle tool
called the Traffic Light Method, which is used to assist
patients in improving their lifestyle. The Traffic Light
Method is a multimodal tool, including a health assess-
ment (‘visual risk profile’), tools for goal setting, (self-
)monitoring of progress and informative text blocks
based on lifestyle guidelines. Mental health (MH) nurses
using the web tool were also trained in motivational
interviewing and the stages-of-change model to be able
to promote behaviour change in SMI patients [12, 20]. A
three-month pilot study showed that the intervention
was effective and feasible: patients receiving the multi-
modal lifestyle intervention (N = 20) on average lost
three kilograms of body weight, performed more phys-
ical activity and rated their general well-being higher
compared to usual-care controls (N = 20) [21].
The primary aim of the pragmatic Lifestyle Interven-
tions for Outpatients with serious mental illness in the
Netherlands (LION) trial was to study the effectiveness
of a twelve-month multimodal lifestyle approach using
the Traffic Light Method in terms of decreasing or sta-
bilizing waist circumference (WC) after six and twelve
months intervention, compared to care-as-usual. The
secondary aim was to study the intervention effect on
cardiometabolic risk. Cardiometabolic risk factors in-
clude Body Mass Index (BMI) and metabolic syndrome.
The latter is a cluster of risk factors related to cardiovas-
cular disease: diabetes and prediabetes, abdominal obes-
ity, high blood pressure and elevated blood lipids
(cholesterol and triglycerides). We hypothesized that the
intervention would lead to stabilized or reduced WC,
BMI and metabolic syndrome.
Method
The LION study protocol has already been published [22]:
it is a pragmatic single-blind multi-site cluster randomized
controlled trial. The Medical Ethical Committee of the
University Medical Center Groningen approved the study.
Eligible patients received an information letter and signed
informed consent before participating in the trial. The
study was performed in accordance with the Declaration
of Helsinki and registered in the Dutch Trial Registry
(NTR3765, www.trialregister.nl, 21 December 2012). The
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trial adheres to the CONSORT guidelines [23] and the
CONSORT-EHEALTH checklist (V.1.6.1) [24].
Participants, recruitment and randomization
SMI patients treated by 21 Flexible Assertive Commu-
nity Treatment (F-ACT) teams [25] and eight sheltered
facility teams of five mental health organizations in the
northern Netherlands (catchment area 3.6 million inhab-
itants) were invited to participate in the study within
twelve months after the inclusion of the teams (January
2014 to October 2015). F-ACT teams offer outreach
mental health care to community-dwelling patients in
their own living environment, ranging from low inten-
sive support to high intensive treatment [25]. When in-
dependent living is not possible, patients may reside in
sheltered facilities in the community where they are sup-
ported in budgeting and other independent living skills.
The F-ACT teams were clustered based on organization,
caseload size, patient mean age, mean duration of pa-
tient admission, most prevalent diagnosis and location
(urban or rural), and were randomized equally between
intervention or control group. Randomization within
eight blocks of two to three teams was performed using
a random number generator by a member of the re-
search team (FJ) not involved in the training of staff or
the recruitment of patients. To avoid spill-over effects of
the intervention, sheltered housing teams which relied
on F-ACT teams for their patients’ mental health care,
were assigned to the same condition as the F-ACT
teams. In some teams, all of the nurses participated,
while in others the team leader selected nurses.
MH nurses invited SMI patients to participate if their
annual physical screening revealed at least one of the fol-
lowing metabolic risk factors: WC > 88/102 cm (females/
males); fasting glucose > 5.6 mmol/L or HbA1c > 5.7%
or > 39 mmol/mol; BMI > 25 kg/m2. Exclusion criteria
were pregnancy, BMI < 19 kg/m2, or impairment in per-
forming physical activity. Patients received an informa-
tion letter and provided written informed consent. In
total, with an alpha = 0.05 and power of 0.80, 275 pa-
tients were required to detect a clinically relevant reduc-
tion of 5.8 cm in the primary outcome for WC [26],
taking into account 10% dropout.
Intervention
The twelve-month multimodal, patient-centred lifestyle
intervention was delivered by MH nurses, and included
the use of the web tool ‘Traffic Light Method for Som-
atic Screening and Lifestyle’ (see below). MH nurses coa-
ched patients by using the web tool during regular care
visits, ideally once every two weeks. Key features of the
intervention were: [1] patient readiness for behaviour
change was not a prerequisite for starting the interven-
tion, [2] patients decided what lifestyle behaviour would
be targeted and created their own lifestyle plan, [3] the
intervention addressed diet and physical exercise and in-
corporated behavioural techniques, [4] active support
from friends and family was incorporated into the life-
style plan, and [5] nurses focused on coaching the pa-
tient and creating a healthier environment in the mental
health care institution, if applicable. The patients’ level
of readiness to change their diet and physical activity be-
haviours was assessed in the web tool, so MH nurses
could better tailor the content of the intervention to the
stages of change.
Nurses received one day of training on: (a) basic com-
ponents of motivational interviewing [10] and the stage-
of-change model [11], (b) side effects of psychotropic
medication, (c) lifestyles of and risks for SMI patients,
(d) working with the web tool Traffic Light Method, and
(e) environmental factors that may influence effectively
working with the Traffic Light Method (e.g. the availabil-
ity of unhealthy products in the home environment). In
addition, the study protocol was explained. After three
months, nurses attended an evaluation session to discuss
obstacles in the use of the tool, obstacles in motivating
patients to participate and to recollect the study proto-
col. Due to the nature of the intervention, the trained
LION nurses were not blind for study allocation.
Patients in the control condition received care-as-
usual, which entails an annual Routine Outcome Moni-
toring (ROM) assessment, of which results are discussed
with patients. They are referred to their GP when ROM
results indicate this is necessary. Lifestyle guidance is
more or less provided when patients express an interest.
The web tool ‘Traffic Light Method for Somatic Screening
and Lifestyle’
The Traffic Light Method was developed as a practical tool
for use by nurses and patients in a Dutch mental health care
organization and further advanced by a small spin-off
company (Charly Green, Bilthoven, the Netherlands). The
Traffic Light Method was constructed based on national
and international guidelines for a healthy diet and physical
activity and on the literature on somatic screening and life-
style coaching, and was adapted after two rounds of Delphi
panel expert discussion [21]. The tool provides knowledge
and incorporates behavioural techniques to elicit behav-
ioural change, such as creating awareness, goal setting, pro-
viding feedback and self-management. The tool addresses
the lifestyle themes of diet, physical activity, medication use,
personal hygiene, stressors, substance use and sexual
behaviour.
The tool consists of a screening phase and a follow-up
phase. In the screening phase, patients and nurses ap-
praise the patient’s lifestyle behaviours. The Traffic Light
Method generates a visual risk profile for each lifestyle
behaviour based on the level of risk, represented by
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green (healthy), orange (medium-healthy) or red (un-
healthy) traffic lights. Based on the lifestyle screening,
patients construct a lifestyle plan with SMART (specific,
measurable, attainable, realistic and timely [27]) behav-
ioural goals. During the follow-up phase, nurses and pa-
tients evaluate the patient’s progress in achieving the
lifestyle goals using follow-up reports during fortnightly
regular care visits for approximately 15 min. After six
months, patients and nurses screen lifestyle behaviours
again, revisit and adjust or create a new lifestyle plan
and evaluate this plan for the next six months until the
intervention ends. In our study, it was estimated that pa-
tients would complete 23 follow-up reports over 12
months, i.e. 26 fortnightly visits minus the visits for the
three lifestyle screening sessions. For a detailed descrip-
tion of the Traffic Light Method, see [21, 22].
Measurements and outcomes
The primary outcome concerned waist circumference
(WC; cm) after six and twelve months intervention. Sec-
ondary outcomes were measured by Body Mass Index
(BMI; kg/m2) and metabolic syndrome Z-score (MS Z-
score; SD), a standardized score for the cluster of five
cardiometabolic risk factors. Information on age, sex,
diagnosis and medication use was derived from patient
record forms. As part of standard care, trained ROM
nurses screen patients annually on physical and psycho-
social outcomes according to protocol [28]. The data
were used for baseline and twelve-month measurements.
For the additional physical exam and lab test after six
months of intervention (six-month measurement), par-
ticipants received a nominal remuneration (EUR 5/USD
5.45). ROM nurses were blinded to treatment allocation.
WC, weight, height, systolic and diastolic blood pres-
sure (BP) were measured according to protocol [22].
Fasting blood samples were collected in a hospital or
other laboratory for levels of lipids (total cholesterol,
LDL-cholesterol, HDL-cholesterol and triglycerides) and
glucose metabolism (glucose, HbA1c). If not fasting, this
was routinely indicated on the form.
Metabolic syndrome (MS) was defined as the pres-
ence of three or more of the following criteria [29]:
WC ≥ 88/102 cm (female/male); systolic BP ≥ 130 and/
or diastolic BP ≥ 85 mmHg or receiving antihyperten-
sive medication; HDL-C < 1.03/1.3 mmol/L (female/
male) or receiving lipid-lowering medication; fasting
triglycerides ≥1.7 mmol/L or receiving lipid-lowering
medication; and fasting glucose ≥6.1 mmol/L [30] or
receiving antihyperglycemic medication. When fasting
glucose levels were not available, patients were consid-
ered to fulfil the glucose risk criterion if they reported
to have diabetes or if HbA1c ≥ 42.0 mmol/mol [31].
Since the dichotomization of the MS components re-
duces sensitivity to changes over time, the individual
components were standardized into Z-scores (with
HDL-cholesterol Z-score multiplied by − 1) [32, 33]
and the sum, divided by five, was used as a continuous
variable for the degree of metabolic syndrome (MS Z-
score). BP was standardized using mean arterial pres-
sure (MAP).
Antipsychotic medication (AP) was categorized into
three groups according to the strength of its side effect on
cardiometabolic health (none, mild or strong) based on
the literature [34, 35] (see e Additional file 1 Table S1).
Patient readiness to change physical activity or dietary be-
haviour was assessed by a question representing the five
phases of the stage-of-change model [11]. Answers ranged
from ‘not willing to change within six months’ (precontem-
plation), ‘willing to change within six months’ (contempla-
tion), ‘willing to change within one month’ (preparation),
‘consider myself acting healthily for less than six months’
(action) to ‘consider myself acting healthily for more than
six months’ (maintenance phase).
The number of follow-up reports in the Traffic Light
Method web tool represents the level of adherence to
the intervention.
Analyses
Results were presented as means (95% confidence
interval) or medians (25-75th percentile). Data were
analysed using SPSS version 22 [36], with a p-value of
0.05 considered statistically significant. The interven-
tion effect was tested using an intention-to-treat ap-
proach with a multi-level, subject-specific linear mixed
model that had an unstructured variance structure,
controlling for teams to adjust for clustering of pa-
tients within teams and adjusting for type of AP medi-
cation. Intervention effects were tested in stratified
analyses of pre-specified subgroups based on sex, age
and type of housing. In explorative per-protocol ana-
lyses, adhering participants (high users) were com-
pared to the control group using the same linear
mixed models as described above. Participants who
completed at least one lifestyle behaviour screening,
constructed lifestyle goals and completed ten or more
follow-up reports were considered high users. We also
compared the percentage of participants who im-
proved or deteriorated by ≥5% in WC or BMI after six
and twelve months between intervention and control
groups using Chi-square tests.
We also used a Chi-square test to determine the inter-
vention effects on patient readiness to change dietary or
physical activity behaviour by comparing the percentage
of intervention participants who had shifted towards
more readiness to change between baseline, six and
twelve months to the percentage of participants in the
control group who had done so.
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Results
In total, 244 patients (140 intervention; 104 control) were
included in the trial, of whom 49.2% were male and the
mean age was 46.1 ± 10.8 years (Table 1). Patients in the
intervention group were on average 4.3 years younger
(p = .002) and had a higher BMI (p = .045) than patients in
the control group. More teams ended up in the interven-
tion (N = 17) than in the control group (N = 10) due to
large reorganizations that took place in mental health care
during the first phase of the trial. This led to teams being
combined, split or disbanded after the randomization pro-
cedure had been completed (Fig. 1) [22].
Results for the intervention and control groups over
time are presented in Fig. 2 and e Additional file 2 Table
S2. In intention-to-treat analyses, WC did not signifi-
cantly differ from the control group after six (-0.15 cm
(-2.49; 2.19)) and after twelve months (-1.03 cm (-3.42;
1.35)) (Table 2). ForBMI and MS Z-score, no significant
differences were found either. Compared to the control
group, no significant intervention effects on WC, BMI
or MS Z-score were found for males vs females, for
younger (≤ 46.0 years) vs older (> 46.0 years) participants
or for F-ACT vs sheltered housing participants (e Add-
itional file 3 Table S3). No differences between the inter-
vention and control groups were found regarding the
percentage of participants who improved or deteriorated
by ≥5% in WC or BMI after six or twelve months.
The use of the web tool during regular care visits was
much lower than the estimated 23 follow-up reports. In
the intervention group, 108 of all 140 (77%) patients
completed at least one lifestyle behaviour screening and
constructed subsequent lifestyle plans with lifestyle goals
(Fig. 3). Of those, low users (N = 13; 12%) had no follow-
up reports, while medium users (N = 60; 56%) and high
users (N = 35; 32%) had medians of 4.0 [2.3; 7.0] and
14.0 [11.0; 18.0] follow-up reports, respectively. Patients
primarily constructed lifestyle goals related to diet (N =
141; 41.7%), physical activity (N = 83; 24.6%) or a com-
bination of both (N = 37; 10.9%), but also related to
smoking (N = 17; 5.0%) and sleeping behaviours (N = 15;
4.4%). At baseline or second measurement, almost all
intervention patients (N = 99; 92%) set at least one goal
related to energy intake or expenditure. Explorative ana-
lyses were conducted in the high-user group: WC
change was − 1.87 cm (− 7.31; 1.56) after six and − 1.69
cm (− 4.96; 1.58) after twelve months of intervention
compared to controls, although this was not statistically
significant. BMI and MS Z-score did not differ over time
in high users compared to controls.
At baseline, the readiness to change physical activity
behaviour differed significantly between the intervention
group and control group: 48 (52.2%) control patients
considered themselves healthy for less or more than six
months with regard to physical activity compared to 32
(29.4%) patients in the intervention group (p < .001)
(Table 1). Although the intervention group thus had
more opportunity to increase readiness to change, over
time, no significantly different changes in stage of
change were found between the groups. With regard to
dietary stage of change at baseline, no differences were
found between the intervention and control groups.
After six months of intervention, more patients in the
intervention group increased in their readiness to change
their dietary behaviours (40% vs 23%) and fewer de-
creased in readiness to change (19% vs 39%), when com-
pared to the control group (p = .049). After twelve
months, 40% of the patients in the intervention group
increased and 26% decreased in their readiness to
change their dietary behaviours, compared to a 20% in-
crease and 29% decrease in the control group (p = .023).
Discussion
Considering the alarming cardiometabolic risks for SMI
patients, staff involved in regular mental health care
practice urgently need tools and training to improve pa-
tient lifestyle. The twelve-month multimodal web-based
intervention facilitating nurses in addressing SMI patient
lifestyle change did not improve the patients’ cardiomet-
abolic health but did improve the patients’ readiness to
change their dietary behaviour. The study shows that the
use of the web tool was lower than expected. The type
of intervention and delivery mode will need optimization
to realize effective lifestyle care for SMI patients.
The results of this trial can be compared to several
recently published pragmatic trials in this field that
have comparable sample sizes and follow-up duration
[37–42]. The results of the trials are inconsistent;
some report significant weight loss in the intervention
group [37–39], while others yield findings comparable
to ours [40–42]. This inconsistency may be due to a
number of reasons, which are discussed below. In our
view, a balance needs to be found, firstly in relation to
the type of intervention offered: should a long-term
patient-centred programme focused on counselling
about lifestyle behaviour be employed, or a high-
intensity short-term programme focused on super-
vised exercise and intensive diet? Secondly, it is im-
portant to determine who can participate in the
lifestyle programme: should all patients be targeted or
only those who are highly motivated and ready, or
only those with high risk? Finally, there must be a bal-
ance in the delivery of the intervention: should it
occur as part of care involving caregivers with whom
the patient is already familiar, or does it require health
professionals specifically trained to provide lifestyle
care?
The outcomes of our trial may have been related to the
type of intervention. In the literature, the more effective
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Table 1 Baseline characteristics of LION study participants
N Total Intervention group Control group p-values
General information
Teams, N 27 17 10
Nurses, N 138 82 56
Patient characteristics
Patients, N 244 140 104
Age, mean ± SD, years 240 46.1 ± 10.8 44.3 ± 10.9 48.6 ± 10.2 .002
Male sex, N (%) 120 (49.2) 66 (47.1) 54 (51.9) .46
Housing, N 240 .38
F-ACT teams (patients) 19 (193) 12 (108) 7 (85)
Sheltered living teams (patients) 8 (51) 5 (32) 3 (19)
Years since first contact MH organisation,
mean ± SD, years
220 17.0 ± 11.0 15.6 ± 11.3 19.0 ± 10.3 .021
Adiposity
Waist circumference, mean ± SD, cm
- male 114 111.3 ± 12.7 112.3 ± 14.2 110.0 ± 10.7 .32
- female 116 110.2 ± 16.3 111.9 ± 17.0 107.8 ± 15.0 .18
Body Mass Index (BMI), mean ± SD, kg/m2 233 32.0 ± 6.4 32.7 ± 7.2 31.1 ± 5.1 .045
BMI categories, N (%): 233 .36
Normal (BMI < 25) 21 (9.0) 11 (8.3) 10 (10.0)
Overweight (25≤ BMI < 30) 81 (34.8) 44 (33.1) 37 (37.0)
Obese I (30 ≤ BMI < 35) 70 (30.0) 40 (30.1) 30 (30.0)
Obese II (35≤ BMI < 40) 36 (15.5) 19 (14.3) 17 (17.0)
Obese III (BMI ≥40) 25 (10.7) 19 (14.3) 6 (6.0)
Blood pressure (BP), mean ± SD, mmHG
Systolic BP 230 133.1 ± 17.0 132.9 ± 17.3 133.4 ± 16.7 .82
Diastolic BP 227 84.1 ± 10.5 85.0 ± 10.5 82.9 ± 10.5 .15
Use of BP lowering medication, No. (%) 171 45 (26.3) 21 (22.1) 24 (31.6) .16
Lipids
Total cholesterol, mean ± SD, mmol/L 199 5.08 ± 1.11 5.17 ± 1.05 4.96 ± 1.18 .20
HDL-cholesterol, mean ± SD, mmol/L
- male 107 1.03 ± 0.23 1.01 ± 0.23 1.05 ± 0.22 .38
- female 103 1.36 ± 0.47 1.35 ± 0.53 1.36 ± 0.37 .95
LDL-cholesterol, mean ± SD, mmol/L 196 3.07 ± 0.94 3.09 ± 0.88 3.05 ± 1.02 .75
Triglycerides, median [25-75th %], mmol/L 94 1.73 [1.08; 2.41] 1.68 [1.03; 2.53] 1.76 [1.22; 2.15] .90
Use of lipid lowering medication, No. (%) 171 45 (26.3) 22 (22.7) 23 (31.1) .22
Glucose metabolism
Fasting glucose, median [25-75th %], mmol/L 93 6.0 [5.4; 7.0] 5.7 [5.3; 7.0] 6.2 [5.7; 7.0] .09
HbA1c, median [25-75th %], (%) 190 36.0 [33.3; 41.0] 36.0 [33.0; 39.0] 38.0 [34.0; 44.0] .009
Diagnosis of diabetesb 235 73 (31.1) 36 (27.1) 37 (36.3) .13
Use of glucose lowering medication, N (%) 162 37 (22.8) 17 (18.5) 20 (28.6) .13
Metabolic syndrome, N (%) 84 56 (66.7) 25 (56.8) 31 (77.5) .37
Metabolic syndrome Z-scorea, mean ± SD, SD 84 0.65 ± 0.92 0.61 ± 0.96 0.69 ± 0.88 .68
Psychiatric characteristics
Psychiatric diagnosis, N (%) 243
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interventions are intensive and include guided exercise ses-
sions [37–39], whereas those with null findings [40–42] are
mainly oriented towards promoting behavioural change
using counselling, including motivational techniques. This
could imply that interventions based on counselling and
education may not be sufficiently effective, and that guided
exercise sessions, in addition to motivational interviewing
techniques, need to be included to achieve health gains.
However, we might also conclude that interventions that
mainly focus on increasing motivation to change unhealthy
behaviours need a longer follow-up period when studying
health outcomes, since health gains should probably be
expected much later when the nurses’ aim is to provide pa-
tients with support to reach personal goals, rather than or-
ganizing this for them. This is illustrated in our study by
the fact that in the intervention group, readiness to change
in diet significantly increased after twelve months. In
addition, those who completed more sessions over a longer
period of time lost more weight in the end than the control
group, albeit not significantly.
The difference in effects that interventions have on
body weight may partly be related to the type of patients
enrolled in the studies. In the studies in which weight
loss was achieved [37–39], patients knew beforehand
Table 1 Baseline characteristics of LION study participants (Continued)
N Total Intervention group Control group p-values
Psychotic disorder 140 (57.6) 86 (61.4) 54 (52.5) .16
Mood disorder 68 (28.0) 36 (25.7) 32 (31.1) .36
Personality disorder 64 (26.3) 34 (24.3) 30 (29.1) .40
Anxiety disorder 33 (13.6) 18 (12.9) 15 (14.6) .70
Psychiatric comorbidityc, N (%) 243 75 (30.9) 40 (28.6) 35 (34.0) .37
Use of antipsychotics, N (%) 217 187 (86.2) 108 (87.8) 79 (84.0) .43
Antipsychotic medication based
on metabolic side effectd, N (%)
224 .74
No effect 71 (31.7) 42 (33.1) 29 (29.9)
Medium effect 76 (33.9) 44 (34.6) 32 (33.0)
High effect 77 (31.7) 41 (32.3) 36 (37.1)
Smoking, yes, N (%) 198 110 (55.6) 60 (55.6) 50 (55.6) .99
Stage of changee, N (%)
Dietary behaviour 209 .13
Pre-contemplation phase 11 (5.3) 5 (4.3) 6 (6.5)
Contemplation phase 51 (24.4) 29 (24.8) 22 (23.9)
Preparation phase 56 (26.8) 39 (33.3) 17 (18.5)
Action phase 21 (10.0) 11 (9.4) 10 (10.9)
Maintenance phase 70 (33.5) 33 (28.2) 37 (40.2)
Physical activity behaviour 201 .00
Pre-contemplation phase 29 (14.4) 12 (11.0) 17 (18.5)
Contemplation phase 49 (24.4) 36 (33.0) 13 (14.1)
Preparation phase 43 (21.4) 29 (26.6) 14 (15.2)
Action phase 18 (9.0) 10 (9.2) 8 (8.7)
Maintenance phase 62 (30.8) 22 (20.2) 40 (43.5)
Note: SI conversion factors: to convert total cholesterol, HDL-cholesterol and LDL-cholesterol to mg/dL, divide values by 0.0259; to convert triglycerides to mg/dL,
divide values by 0.0113; to convert fasting glucose to mg/dL, divide values by 0.0555. Baseline differences were tested with Student’s T, Mann Whitney U or Chi
square tests. Bold p-values denote statistical significance at the p < 0.05 level
a The means and standard deviations (SD) of the patients ranging within healthy reference values were used to standardize HDL-C (1.1–2.0 mmol/L in female and
0.9–1.7 mmol/L in male patients), triglycerides (≤ 2.2 mmol/L) and fasting glucose (≤ 7.1 mmol/L) or HbA1c (< 8.0%)
b Diabetes was defined based on reported diagnosis of diabetes, use of antihyperglycemic medication, fasting glucose ≥7.1 mmol/L or HbA1c ≥ 48mmol/mol
c Two or more of the defined diagnoses
d If no antipsychotic medication was used, this was categorized as the no effect group
e Pre-contemplation phase ‘I am eating (a little bit) unhealthily and do not intend to eat healthily in six months’; Contemplation phase ‘I am eating (a little bit)
unhealthily and intend to eat healthily in six months’; Preparation phase ‘I am eating (a little bit) unhealthily and intend to eat healthily in one month’; Action
phase ‘I have eaten healthily for less than six months’; Maintenance phase ‘I have eaten healthily for more than six months’. For stage of change for physical
activity behaviour, eating was replaced by activity (e.g. ‘My activity is (a little bit) unhealthy and I do not intend to act healthily in six months’, etc.)
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that structured and guided exercise sessions were part of
the intervention and, thus, it is most likely that they
were highly motivated and willing to take part in such
an intervention. One drawback of this strategy is that it
may compromise external validity [43], as some studies
have indeed reported [38, 39]. In contrast, while the
STEPWISE trial reported having no trouble recruiting
and retaining patients in the trial, intervention uptake
was a challenge [41].
The findings may also be inconsistent because study
participants may have differed in their baseline risk.
The more effective trials included participants with a
BMI ≥25 kg/m2, whereas the trials with null findings in-
cluded patients with an interest in lifestyle (change)
[40–42] or, in our case, meeting one of three inclusion
criteria regarding metabolic risk. As a result, apart from
the STEPWISE trial, mean baseline BMI levels were
lower in the studies without effect. Naslund (2016)
showed that a higher BMI at baseline is associated with
more weight change upon intervention [44], supporting
our observation.
With regard to the delivery of the intervention, we
chose MH nurses, who included the intervention in their
regular care contact sessions. The number of completed
screenings and follow-up reports indicates that treat-
ment adherence was lower than expected, suggesting
that it may have been difficult for the nurses to carry
out the intervention as part of their regular work. In the
more effective trials [37–39], specially appointed profes-
sionals were allocated dedicated hours for lifestyle
coaching and exercise guidance with the exclusive prior-
ity to improve patient lifestyle. In other words, lifestyle
coaching requires specific knowledge, skills and dedi-
cated time, and should probably be the responsibility of
professional lifestyle coaches rather than an additional
task of nurses.
Fig. 1 Flow chart of patients in the LION trial
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In summary, regarding aspects of the type of inter-
vention, patient inclusion and delivery of the lifestyle
care, all approaches may differ with regard to the ef-
fectiveness in the short term, and in their respective
advantages and disadvantages. More insight is needed
into the long-term effects of these trials to warrant
fair comparisons in terms of effectiveness, and to de-
cide what strategies, or combinations of strategies, are
best to provide effective lifestyle care for patients with
a serious mental illness.
Limitations
Several factors may have influenced the implementation
and impact of the intervention. Large budget cutbacks in
mental health organizations at the start of this trial resulted
in an unexpected increased workload for MH professionals
and the transfer of SMI patients to a more limited form of
general mental health care. This may have negatively af-
fected the MH nurses’ opportunity and motivation to im-
plement the intervention [45] on the one hand, and may
have caused loss to follow-up of probably the most stable
patients, on the other hand. Furthermore, although most
nurses had received MI training before, the MI skills of
some nurses might have been insufficient to increase pa-
tients’ intrinsic motivation. Regretfully, we have no audio-
recordings of the lifestyle sessions that would enable us to
measure the level of fidelity in motivational interviewing
techniques. However, of note in this respect is that the
STEPWISE trial did not yield significant results, despite the
reported high fidelity in motivational interviewing tech-
niques [41]. Furthermore, filling in the follow-up reports
was reported to take much longer than the expected fifteen
Fig. 2 Somatic outcomes at baseline, six and twelve months per condition. Legend: Estimated marginal means and standard errors for: a) waist
circumference, b) BMI and c) metabolic syndrome Z-score for intervention and control groups at baseline, six and twelve months.
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minutes per regular care visit. Some nurses also experi-
enced practical problems, such as no computer/laptop
available or no access to the internet in rural areas.
Conclusion
The Traffic Light Method is a multimodal tool, which in-
cludes a health assessment (‘visual risk profile’), tools for
goal setting, (self-)monitoring of progress and informative
text blocks based on lifestyle guidelines. Nurses using the
web tool were trained in motivational interviewing and the
stages-of-change model to be able to promote behaviour
change in SMI patients. Using this tool did not improve car-
diometabolic health. It did, however, improve the readiness
to change dietary behaviour. Interventions mainly focusing
Fig. 3 Intervention adherence of patients in the LION trial. Legend: If participants completed at least one lifestyle behaviour screening and
constructed a lifestyle plan with lifestyle goals, they were considered a low user when no follow-up reports were completed; a medium user
when between one and nine follow-up reports were completed; and a high user when ten or more follow-up reports were completed.
Table 2 Somatic outcomes after six and twelve months of lifestyle intervention in SMI patients. Results of general linear mixed






Z-score (N = 115)
β 95% CI p-value β 95% CI p-value β 95% CI p-value
Intervention effecta
at 6 monthsb −0.15 [− 2.49; 2.19] .90 0.27 [−0.32; 0.85] .38 −0.25 [− 0.69;0.18] .24
at 12 monthsb −1.03 [−3.42; 1.35] .39 0.18 [−0.49; 0.86] .60 −0.30 [−0.66; 0.05] .09
Group difference (intervention vs control) 2.26 [−3.91; 8.44] .45 1.47 [−0.17; 3.11] .08 −0.10 [−0.54; 0.34] .63
Time effect only
6 months −0.15 [−1.84; 1.54] .86 −0.15 [−0.57; 0.27] .49 0.10 [−0.19; 0.40] .48
12months 1.56 [−0.23; 3.34] .08 −0.26 [−0.77; 0.24] .31 0.08 [−0.17; 0.33] .51
AP med. Side effectc
Medium 1.99 [−0.91; 4.90] .18 0.90 [−0.01; 1.81] .05 −0.07 [−0.51; 0.36] .74
High 0.17 [−3.04; 3.38] .92 0.08 [−1.09; 1.25] .90 0.40 [0.00; 0.80] .049
Abbreviations: AP medication side effect: antipsychotic medication side effect on metabolism; CI: confidence interval.
a control group is reference
b group x time
c no AP medication side effect is reference
Bold p-values denote statistical significance at the p < 0.05 level
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on increasing motivation and readiness to change might
need a much longer follow-up, as it takes time to translate
intentions into actual behaviour change, especially in this
vulnerable population. A comparison of our results with
those in the existing literature suggests that both the type of
intervention and the delivery mode need optimization to
realize effective lifestyle care for SMI patients. In addition,
we propose that lifestyle coaching for SMI patients be con-
sidered a complex specialization demanding specific know-
ledge and skills, and that it should thus not be one of the
many tasks assigned to MH nurses, but rather the responsi-
bility of appointed lifestyle professionals.
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1186/s12888-019-2310-5.
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